0001209191-20-004465.txt : 20200122 0001209191-20-004465.hdr.sgml : 20200122 20200122162011 ACCESSION NUMBER: 0001209191-20-004465 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200116 FILED AS OF DATE: 20200122 DATE AS OF CHANGE: 20200122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Daniel Lee CENTRAL INDEX KEY: 0001713712 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 20539129 MAIL ADDRESS: STREET 1: C/O DECIPHERA PHARMACEUTICALS, LLC STREET 2: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 200 SMITH STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-01-16 2020-01-21 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001713712 Flynn Daniel Lee C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 3.95 2020-01-16 4 M 0 10106 0.00 D 2026-09-26 Common Stock 10106 4944 D This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of July 1, 2016, subject to continued service through such dates. This form 4 amendment is being filed to report an incorrect number in Table II, column 9. /s/ Thomas P. Kelly, Attorney-in-Fact 2020-01-22